Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Abnormal Uterine Bleeding (AUB) significantly impacts women's quality of life, with heavy and irregular bleeding being common issues. The Levonorgestrel-releasing Intrauterine System (LNG-IUS), such as Mirena, is an effective long-term treatment that reduces menstrual blood loss and regulates cycles, offering an alternative to hysterectomy. Women’s acceptance of Mirena depends on its effectiveness, side effects and personal preferences. Understanding their experiences with Mirena, regarding daily life improvements and overall satisfaction is crucial for managing AUB and enhancing patient-centered care. To study the acceptance and quality of living of Mirena Intrauterine Device (IUD) for AUB(A) and AUB(E) among patients with Abnormal Uterine Bleeding. This observational study was conducted among 143 female patients with Abnormal Uterine Bleeding attending the outpatient department of a tertiary care hospital. Institutional ethics committee approval has been obtained. After obtaining informed consent, information was collected regarding acceptance and quality of life with Mirena for AUB(A) and AUB(E) using the WHOQOL-BREF questionnaire from the study participants. In this study, 143 patients came with the history of AUB. Out of which 21 patients agreed for surgery and 122 patients were under conservative medical management. Among them 16 patients had MIRENA for AUB(A) and AUB(E). CONCLUSION: Mirena effectively manages AUB by reducing bleeding and improving quality of life, making it a wellaccepted alternative to surgical treatments. Enhancing awareness and addressing patient concerns can further improve acceptance and satisfaction with its use.
How to cite this article:
Deeksha Pandey, Pranadeep Reddy Inukollu and L. Bhuvaneswari. Mirena for AUB(A) and AUB(E): Acceptance and Quality of Life.
DOI: https://doi.org/10.36478/makrjms.2024.12.827.833
URL: https://www.makhillpublications.co/view-article/1815-9346/makrjms.2024.12.827.833